loader image
Saturday, November 29, 2025
83 F
McAllen
- Advertisement -

Cervical Cancer Prevention

Translate to Spanish or other 102 languages!

In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease. Courtesy Image
In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease. Courtesy Image

Mega Doctor News

- Advertisement -

Regular pap tests and HPV testing can prevent and often catch cases of cervical cancer.

Each year, approximately 13,000 women are diagnosed with cervical cancer and about 4,000 women die from cervical cancer in the US. Sixty percent of cervical cancers occur in resource- poor communities.

In Texas, Hispanic women have a higher incidence (15.1 per 100,000 women, compared to 8.1 per 100,000 among white women) and are 1.9 times more likely to die from the disease.

- Advertisement -

Hispanic women residing on the US-Mexico border have even higher cervical cancer incidence rates, a high late-diagnosis rate, and one of the highest mortality rates in the US.

Screening rates among Hispanic women along the border are suboptimal.

Courtesy Image

At Texas Tech University Health Sciences Center El Paso, the De Casa en Casa program is reducing the burden of cervical cancer by facilitating early diagnosis and access to treatment. The program offers educational sessions, no-cost cancer screenings, and diagnostic testing. The program covers 105 West Texas counties, including El Paso and Hudspeth counties.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×